Evidence map›Paper›PMID 42539785›Full record

ArticleCureus2026

The Micronizer: A Novel Sharp-Bladed Device for Fat Graft Micronization to Optimize Adipocyte Viability.

Oscar A Vazquez, Nicholas De Leo, Hilton Becker

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Oscar A VazquezSurgery, University of Florida, Gainesville, USA.
Nicholas De LeoPlastic and Reconstructive Surgery, Cleveland Clinic Florida, Weston, USA.
Hilton BeckerSurgery, Florida Atlantic University, Boca Raton, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reducing fat particle size before injection is anticipated to promote adipocyte survival and facilitate injection through smaller cannulas or needles. We present the Micronizer (Marina Medical, Davie, FL), a Luer-to-Luer connector housing an ultrasharp, double-sided blade that reduces fat particle size through direct sharp dissection rather than mechanical emulsification. Through its dual-configuration design, comprising 2.4- and 1.2-mm apertures, the Micronizer cuts directly along the axis of fat passage, enabling stepwise reduction in particle size. Fat harvested using a 2.5-3.0-mm cannula is processed by repeated passage between syringes through the device. The direct sharp-cutting mechanism is anticipated to reduce fat particle size while limiting compressive forces, with the goal of preserving graft viability. We describe the complete processing protocol. The Micronizer offers a standardized, reproducible method for fat graft micronization that achieves particle sizes anticipated to be optimal for vascularization. Potential applications include revision breast reconstruction, primary breast reconstruction, breast augmentation, and facial rejuvenation. Comparative studies evaluating cell viability and long-term volume retention are warranted to validate the anticipated advantages of direct sharp-blade processing over conventional compressive techniques.

Indexed as

adipocyte viabilitybody contouringfat graftinglipoaspirationstromal vascular fraction

Identifiers

PMID42539785
PMCPMC13424540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.